5 Stock Gainers Thursday: Moderna, Novavax, Kirkland's

Stocks trading higher Thursday include Moderna, U.S. Auto Parts Network, Novavax, Kirkland's and Retractable Technologies.
Publish date:

Stocks finished lower Thursday as investors reacted to a mixed picture on the health of the U.S. economy.

The number of Americans filing for unemployment insurance since the coronavirus pandemic in March neared 50 million as first-time jobless claims continued to rise.

Retail sales rose 7.5% in June, the second straight month of sharp gains, but economists have expressed concern that next month could be weaker as a surge in coronavirus cases has many states and businesses again locking down.

Despite the sobering news, there were some winners to be found. Here are some of the big movers in the stock market Thursday:

1. U.S. Auto Parts Network | Percentage Increase Over 3%

The Street Quant Rating rates U.S. Auto Parks Network a Sell with a rating score of D-.

U.S. Auto Parts Network  (PRTS) - Get Report said Thursday that Nanxi Liu, CEO and co-founder of Enplug, joined the board. Last month, the company was added to the Russell 2000.

2. Retractable Technologies | Percentage Increase Over 15%

The Street Quant Rating rates Retractable Technologies a Hold with a rating score of C+.

Retractable Technologies  (RVP) - Get Report was recently awarded $53.6 million in U.S. government funding to increase syringe and needle manufacturing capacity to meet potential demand related to the covid-19 coronavirus

3. Novavax | Percentage Increase Over 8%

The Street Quant Ratings Rates Novavax a Sell with a rating score of D-.

Novavax  (NVAX) - Get Report recently announced that it was getting $1.6 billion from the U.S. government to develop a potential vaccine for Covid-19..

4. Kirkland's | Percentage Increase Over 13%

The Street Quant Ratings Rate Kirkland's a Sell with a rating score of D.

Kirkland's  (KIRK) - Get Report said recently that while its stores were closed, online sales and curbside pickups have driven sales. 

5. Moderna | Percentage Increase Over 1%

The Street Quant Ratings Rates Moderna a Sell with a rating score of D+

Moderna  (MRNA) - Get Report recently confirmed that it was still on track to begin its final-stage coronavirus vaccine trial on July 27.